Long-term ketogenic diets have been associated with reductions in bone mineral density in clinical populations, particularly children treated for refractory epilepsy. Clinical teams led by John M. Freeman Johns Hopkins University and Eric H. Kossoff Johns Hopkins University and researchers at Massachusetts General Hospital Elizabeth Thiele have documented lower bone density and increased markers of bone turnover in patients on prolonged ketogenic therapy, indicating real-world concern beyond theoretical risk. Evidence primarily comes from specialty clinics following children with complex medical needs, so risk magnitude may differ for otherwise healthy adults.
Mechanisms linking ketogenic metabolism to bone loss
Several biologic pathways plausibly connect sustained carbohydrate restriction and nutritional ketosis to changes in bone. Chronic mild metabolic acidosis associated with ketone bodies can stimulate bone resorption to buffer acid. Lower circulating insulin and reduced insulin-like growth factor 1 blunt osteoblastic bone formation, and restrictive food patterns often reduce intakes of calcium and vitamin D while increasing urinary calcium loss. Concomitant use of antiseizure medications in pediatric populations further compounds risk by impairing vitamin D metabolism and bone turnover. These mechanisms are described in clinical reviews from pediatric neurology centers and endocrinology literature.
Consequences, risk groups, and contextual factors
Clinically the main consequences are reduced peak bone mass accrual in children and adolescents, and a potential increase in fracture risk over time for adults. Populations most vulnerable include growing children on medically supervised ketogenic therapy, older adults with low baseline bone mass, and people with dietary or cultural practices that limit calcium or vitamin D sources. Geographic factors such as low sunlight exposure can worsen vitamin D deficiency risk, and food culture that avoids dairy may amplify dietary shortfalls. Findings from epilepsy clinics may not translate directly to short-term ketogenic weight-loss regimens, but they highlight biologically plausible harms that warrant attention.
Careful monitoring of bone health, ensuring adequate calcium and vitamin D intake, addressing modifiable medication effects, and incorporating weight-bearing activity are common clinical responses advocated by practitioners experienced in ketogenic therapy. Ongoing, well-controlled long-term studies led by multidisciplinary teams are needed to quantify risk across age groups and dietary patterns and to inform evidence-based guidance.